Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b):
SEC Accession No. 0001213900-24-029928
Filing Date
2024-04-03
Accepted
2024-04-03 17:19:59
Documents
4
Period of Report
2024-04-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K12B ea0203267-8k12b_newgenivf.htm 8-K12B 18418
2 EXHIBIT 99.1 ea020326701ex99-1_newgenivf.htm EX-99.1 9860
3 GRAPHIC image_001.jpg GRAPHIC 4989
4 GRAPHIC image_002.jpg GRAPHIC 4989
  Complete submission text file 0001213900-24-029928.txt   43540
Mailing Address 1/F, PIER 2, CENTRAL HONG KONG K3 999077
Business Address 13/F, PS TOWER, SUKHUMVIT 21 RD (ASOKE) BANGKOK W1 0000 852-2861-1666
NewGenIvf Group Ltd (Filer) CIK: 0001981662 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8
Type: 8-K12B | Act: 34 | File No.: 001-42004 | Film No.: 24820107
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)